Literature DB >> 17439395

Design criteria for a modular tissue-engineered construct.

Alison P McGuigan1, Michael V Sefton.   

Abstract

A modular construct, created by the assembly of discrete microscale objects, has been proposed to enable the engineering of large, vascularized tissues containing multiple cell types. A simple theoretical analysis of the design constraints relevant to a modular construct was performed and used to define useable device operating ranges. The analysis assumed that the primary design constraint was the operating wall shear stress that would lead to a non-thrombogenic endothelial cell layer. At the lower end of the desirable shear range, oxygen depletion (over the length of the construct) limited the maximum allowed construct length, whereas at the upper end of this shear range, construct pressure difference limited maximum construct length. To compare with the theoretical analysis, real constructs were assembled, and construct porosity was assessed using superficial velocity-pressure difference profiles. Significant deviations from ideal construct porosity were observed for soft collagen gel constructs. Improvement of the module mechanical properties through the use of poloxamine instead of collagen as the module material enabled constructs closer to the ideal case to be assembled. With such improvements, modular tissue engineering offers a feasible strategy for the development of clinically significant whole-organ replacements.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17439395     DOI: 10.1089/ten.2006.0245

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  11 in total

1.  Toward an in vitro vasculature: differentiation of mesenchymal stromal cells within an endothelial cell-seeded modular construct in a microfluidic flow chamber.

Authors:  Omar F Khan; M Dean Chamberlain; Michael V Sefton
Journal:  Tissue Eng Part A       Date:  2011-12-02       Impact factor: 3.845

2.  Fabrication of micro-tissues using modules of collagen gel containing cells.

Authors:  M Dean Chamberlain; Mark J Butler; Ema C Ciucurel; Lindsay E Fitzpatrick; Omar F Khan; Brendan M Leung; Chuen Lo; Ritesh Patel; Alexandra Velchinskaya; Derek N Voice; Michael V Sefton
Journal:  J Vis Exp       Date:  2010-12-13       Impact factor: 1.355

3.  Fibrillized peptide microgels for cell encapsulation and 3D cell culture.

Authors:  Ye F Tian; Jason M Devgun; Joel H Collier
Journal:  Soft Matter       Date:  2011-05-23       Impact factor: 3.679

4.  The thrombogenicity of human umbilical vein endothelial cell seeded collagen modules.

Authors:  Alison P McGuigan; Michael V Sefton
Journal:  Biomaterials       Date:  2008-03-05       Impact factor: 12.479

5.  Self-assembly and tissue fusion of toroid-shaped minimal building units.

Authors:  Christine M Livoti; Jeffrey R Morgan
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

6.  Perfusion and characterization of an endothelial cell-seeded modular tissue engineered construct formed in a microfluidic remodeling chamber.

Authors:  Omar F Khan; Michael V Sefton
Journal:  Biomaterials       Date:  2010-08-03       Impact factor: 12.479

7.  Bone marrow-derived mesenchymal stromal cells enhance chimeric vessel development driven by endothelial cell-coated microtissues.

Authors:  Michael Dean Chamberlain; Rohini Gupta; Michael V Sefton
Journal:  Tissue Eng Part A       Date:  2011-10-21       Impact factor: 3.845

Review 8.  Engineering hydrogels as extracellular matrix mimics.

Authors:  Hikmet Geckil; Feng Xu; Xiaohui Zhang; SangJun Moon; Utkan Demirci
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

9.  Effectiveness factor and diffusion limitations in collagen gel modules containing HepG2 cells.

Authors:  Lindsay Corstorphine; Michael V Sefton
Journal:  J Tissue Eng Regen Med       Date:  2011-02       Impact factor: 3.963

10.  Hydrogels in regenerative medicine.

Authors:  Brandon V Slaughter; Shahana S Khurshid; Omar Z Fisher; Ali Khademhosseini; Nicholas A Peppas
Journal:  Adv Mater       Date:  2009-09-04       Impact factor: 30.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.